| Literature DB >> 26608261 |
Nobuhiro Akuzawa1, Hiroshi Naito2.
Abstract
BACKGROUND: Pneumococcal pneumonia is the most common form of community-acquired pneumonia (CAP). Although a pneumococcal conjugate vaccine has contributed to a reduction in the incidence of pneumococcal pneumonia among older children and adults, no significant decrease in the incidence has been observed among persons aged ≥65 years. A low body mass index and hypoalbuminemia are common in Japanese patients with CAP, but the association of other nutritional parameters with the severity of pneumonia or length of hospital stay in patients with pneumococcal pneumonia is unclear.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26608261 PMCID: PMC4658754 DOI: 10.1186/s12890-015-0143-7
Source DB: PubMed Journal: BMC Pulm Med ISSN: 1471-2466 Impact factor: 3.317
Comparison of patient characteristics and inflammatory and nutritional parameters between the ≥65- and <65-year-old groups
| ≥65 years ( | <65 years ( |
| |
|---|---|---|---|
|
| |||
| Mean age (years) | 80.1 ± 7.7 | 44.5 ± 13.9 | <0.001* |
| Sex (male/female) | 13/23 | 12/9 | 0.123 |
| Body mass index (kg/m2) | 18.7 ± 4.1 | 19.6 ± 2.1 | 0.284 |
| CURB-65 score on admission | 1.9 ± 0.9 | 0.5 ± 0.9 | <0.001* |
| PSI on admission | 105.6 ± 24.5 | 28.2 ± 46.2 | <0.001* |
|
| |||
| White blood cell count (/mm3) | 12,750 ± 6490 | 13,300 ± 5460 | 0.744 |
| C-reactive protein (mg/dL) | 12.57 ± 11.97 | 9.60 ± 9.56 | 0.297 |
|
| |||
| Lymphocyte count (/mm3) | 1415.6 ± 1211.5 | 1664.0 ± 531.0 | 0.378 |
| Serum albumin (g/dL) | 3.27 ± 0.59 | 3.76 ± 0.64 | 0.005* |
| Total cholesterol (mg/dL) | 167.5 ± 49.7 | 170.3 ± 43.5 | 0.833 |
| Serum cholinesterase (IU/L) | 189.8 ± 54.3 | 237.0 ± 78.1 | 0.010* |
CURB-65 confusion, urea, respiratory rate, blood pressure, age >65 years, PSI pneumonia severity index
*Statistically significant (P < 0.05)
Correlation between CURB-65 score/PSI and independent variables including age, body mass index, and nutritional parameters
| A. Univariate analysis of correlations between CURB-65 score and independent variables | ||
| Independent variables | ≥65 years ( | <65 years ( |
| Age | 0.235 (0.167) | 0.463 (0.034*) |
| Body mass index | −0.025 (0.883) | −0.210 (0.361) |
| Lymphocyte count | −0.164 (0.338) | −0.197 (0.392) |
| Serum albumin | −0.249 (0.142) | 0.015 (0.948) |
| Total cholesterol | −0.248 (0.146) | −0.270 (0.237) |
| Serum cholinesterase | −0.122 (0.477) | −0.424 (0.056) |
| B. Univariate analysis of correlations between PSI and independent variables | ||
| Independent variables | ≥65 years ( | <65 years ( |
| Age | 0.467 (0.004*) | 0.640 (0.002*) |
| Body mass index | −0.084 (0.627) | −0.012 (0.958) |
| Lymphocyte count | −0.263 (0.122) | −0.145 (0.531) |
| Serum albumin | −0.156 (0.365) | −0.076 (0.744) |
| Total cholesterol | −0.287 (0.089) | −0.016 (0.946) |
| Serum cholinesterase | −0.148 (0.388) | −0.367 (0.102) |
*P < 0.05. Data are presented as correlation coefficient (P-value)
Correlation between CURB-65 score/PSI and independent variables including age, body mass index, and nutritional parameters
| Multivariate linear regression analysis | |||||
| 1. Factors associated with PSI in the ≥65-year-old group ( | |||||
| Independent variable | B (95 % CI) | β |
| VIF |
|
| Age | 1.477 (0.504–2.450) | 0.467 | 3.084 | 1.000 | 0.004* |
| 2. Factors associated with CURB-65 score in the <65-year-old group ( | |||||
| Independent variables | B (95 % CI) | β |
| VIF |
|
| Age | 0.030 (0.004–0.056) | 0.450 | 2.429 | 1.001 | 0.026* |
| Serum cholinesterase | −0.005 (−0.009 to −0.000) | −0.409 | −2.208 | 1.001 | 0.040* |
| 3. Factors associated with PSI in the <65-year-old group ( | |||||
| Independent variables | B (95 % CI) | β |
| VIF |
|
| Age | 2.096 (0.962–3.229) | 0.629 | 3.886 | 1.001 | 0.001* |
| Serum cholinesterase | −0.205 (−0.406 to −0.004) | −0.347 | −2.142 | 1.001 | 0.046* |
(r = 0.467; r 2 = 0.219; 2 adjusted r 2 = 0.196)
r multiple correlation coefficient, r 2 coefficient of determination, B nonstandardized regression coefficient, CI confidence interval; β standardized regression coefficient; VIF variance inflation factor.
*P < 0.05
Comparison of clinical course, caloric intake, and selected antibiotics during hospitalization
| ≥65 years ( | <65 years ( |
| |
|---|---|---|---|
|
| |||
| Length of stay (days) | 17.5 ± 12.9 | 9.0 ± 3.4 | 0.001* |
| Fasting period (days) | 2.7 ± 7.2 | 0.2 ± 0.8 | 0.022* |
| Duration of PPN implementation (days) | 8.4 ± 11.4 | 2.7 ± 2.6 | 0.014* |
| Duration of antibiotic administration (days) | 8.9 ± 2.6 | 6.7 ± 2.9 | 0.002* |
|
| |||
| Oral ingestion (kcal/day) | 1357.9 ± 533.1 | 1652.4 ± 366.5 | 0.030* |
| PPN (kcal/day) | 266.9 ± 49.4 | 144.8 ± 153.6 | 0.034* |
|
| |||
| High-dose ABPC | 18 | 13 | 0.384 |
| Ceftriaxone | 6 | 6 | 0.288 |
| Meropenem | 12 | 2 | 0.044* |
PPN peripheral parenteral nutrition, ABPC aminobenzylpenicillin
*P < 0.05
Correlations between length of stay and independent variables in univariate analysis
| Independent variables | ≥65 years ( | <65 years ( |
|---|---|---|
| Age | 0.479 (0.003*) | −0.062 (0.788) |
| Body mass index | −0.488 (0.003*) | −0.145 (0.532) |
|
| ||
| Lymphocyte count | 0.305 (0.071) | −0.163 (0.480) |
| Serum albumin | −0.527 (0.001*) | −0.542 (0.011*) |
| Total cholesterol | 0.244 (0.152) | −0.558 (0.009*) |
| Serum cholinesterase | −0.516 (0.001*) | −0.493 (0.023*) |
|
| ||
| Fasting period | 0.567 (<0.001*) | 0.403 (0.070) |
| Oral caloric intake | −0.445 (0.007*) | 0.077 (0.740) |
| PPN caloric intake | 0.163 (0.342) | 0.237 (0.301) |
| PPN duration | 0.832 (<0.001*) | 0.115 (0.620) |
|
| ||
| CURB-65 score | 0.295 (0.146) | 0.438 (0.047*) |
| PSI | 0.146 (0.396) | 0.282 (0.215) |
*P < 0.05. Data are presented as correlation coefficient (P-value)
Multivariate stepwise linear regression analysis of factors associated with length of stay
| 1. Factors associated with length of stay in the ≥65-year-old group ( | |||||
| Independent variables | B (95 % CI) | β |
| VIF |
|
| Fasting period | 0.718 (0.239–1.198) | 0.399 | 3.055 | 1.340 | 0.005* |
| Lymphocyte count | 0.003 (0.001–0.006) | 0.315 | 2.680 | 1.086 | 0.012* |
| Serum albumin | −6.345 (−11.778 to −0.913) | −0.292 | −2.382 | 1.176 | 0.024* |
| Age | 0.446 (0.012–0.880) | 0.267 | 2.098 | 1.086 | 0.044* |
| 2. Factors associated with hospitalization period in the <65-year-old group ( | |||||
| Independent variable | B (95 % CI) | β |
| VIF |
|
| Serum total cholesterol | −0.043 (−0.074 to −0.012) | −0.558 | 3.055 | 1.000 | 0.009* |
*P < 0.05